Bupropion hydrochloride
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
492 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Depression | D003863 | — | F33.9 | 5 | 16 | 19 | 39 | 18 | 94 |
| Depressive disorder | D003866 | EFO_1002014 | F32.A | 9 | 14 | 19 | 34 | 16 | 91 |
| Major depressive disorder | D003865 | EFO_0003761 | F22 | 5 | 12 | 19 | 32 | 12 | 79 |
| Tobacco use disorder | D014029 | — | F17 | 6 | 22 | 14 | 23 | 15 | 74 |
| Smoking cessation | D016540 | EFO_0004319 | — | 2 | 10 | 14 | 15 | 23 | 63 |
| Obesity | D009765 | EFO_0001073 | E66.9 | 2 | 16 | 15 | 18 | 6 | 49 |
| Healthy volunteers/patients | — | — | — | 31 | — | — | 2 | 3 | 36 |
| Smoking | D012907 | EFO_0004318 | — | 3 | 7 | 6 | 9 | 12 | 33 |
| Schizophrenia | D012559 | EFO_0000692 | F20 | — | 6 | 2 | 9 | 1 | 18 |
| Overweight | D050177 | — | E66.3 | 1 | 7 | 9 | 2 | 2 | 18 |
Show 85 more
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | — | C80 | 3 | — | 1 | — | 5 | 9 |
| Alzheimer disease | D000544 | EFO_0000249 | F03 | 1 | 1 | 6 | — | — | 7 |
| Bulimia | D002032 | — | F50.2 | — | 6 | 6 | — | 1 | 7 |
| Feeding and eating disorders | D001068 | — | F50 | — | 6 | 6 | — | 1 | 7 |
| Binge-eating disorder | D056912 | — | F50.2 | — | 6 | 6 | — | 1 | 7 |
| Cocaine-related disorders | D019970 | — | F14 | 2 | 3 | 3 | — | 1 | 7 |
| Psychomotor agitation | D011595 | — | — | — | 2 | 6 | — | — | 6 |
| Opioid-related disorders | D009293 | EFO_0005611 | F11 | 2 | 2 | 1 | — | 1 | 4 |
| Anxiety disorders | D001008 | EFO_0006788 | F41.1 | — | 1 | 2 | — | 1 | 3 |
| Non-small-cell lung carcinoma | D002289 | — | — | 1 | 1 | 1 | — | 1 | 3 |
Show 18 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Marijuana abuse | D002189 | EFO_0007191 | F12 | — | 2 | — | — | 1 | 3 |
| Pregnancy | D011247 | EFO_0002950 | Z33.1 | — | 1 | — | — | 2 | 3 |
| Amphetamine-related disorders | D019969 | EFO_0004701 | F15 | 1 | 2 | — | — | — | 3 |
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 1 | 1 | — | — | — | 2 |
| Insulin resistance | D007333 | EFO_0002614 | E88.819 | — | 1 | — | — | 1 | 2 |
| Chronic renal insufficiency | D051436 | — | N18 | — | 1 | — | — | 1 | 2 |
| Stroke | D020521 | EFO_0000712 | I63.9 | — | 1 | — | — | 1 | 2 |
| Coronary artery disease | D003324 | — | I25.1 | — | 1 | — | — | 1 | 2 |
| Carcinoma | D002277 | — | C80.0 | 1 | 1 | — | — | — | 2 |
| Binge drinking | D063425 | — | — | — | 2 | — | — | — | 2 |
Show 17 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Drug interactions | D004347 | — | — | 4 | — | — | — | 1 | 5 |
| Drug-related side effects and adverse reactions | D064420 | — | T88.7 | 1 | — | — | — | 1 | 2 |
| Squamous cell carcinoma of head and neck | D000077195 | — | — | 1 | — | — | — | 1 | 2 |
| Tuberculosis | D014376 | EFO_0000774 | A15-A19 | 1 | — | — | — | 1 | 2 |
| Pulmonary tuberculosis | D014397 | EFO_1000049 | A15 | 1 | — | — | — | 1 | 2 |
| Metabolism | D008660 | GO_0008152 | — | 1 | — | — | — | 1 | 2 |
| Melanoma | D008545 | — | — | 1 | — | — | — | — | 1 |
| Mitochondrial diseases | D028361 | EFO_0000591 | — | 1 | — | — | — | — | 1 |
| Ovarian epithelial carcinoma | D000077216 | — | — | 1 | — | — | — | — | 1 |
| Prostatic neoplasms | D011471 | — | C61 | 1 | — | — | — | — | 1 |
Show 11 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Periodontitis | D010518 | EFO_0000649 | K05.3 | — | — | — | — | 2 | 2 |
| Congenital abnormalities | D000013 | EFO_0003915 | Q89.9 | — | — | — | — | 2 | 2 |
| Lactation | D007774 | — | — | — | — | — | — | 1 | 1 |
| Generalized anxiety disorder | D000098647 | — | — | — | — | — | — | 1 | 1 |
| Health behavior | D015438 | — | — | — | — | — | — | 1 | 1 |
| Palliative care | D010166 | — | — | — | — | — | — | 1 | 1 |
| Kidney diseases | D007674 | EFO_0003086 | N08 | — | — | — | — | 1 | 1 |
| Vitamin d deficiency | D014808 | EFO_0003762 | E55 | — | — | — | — | 1 | 1 |
| Avitaminosis | D001361 | EFO_0005878 | E56.9 | — | — | — | — | 1 | 1 |
| Pharmacokinetics | D010599 | — | — | — | — | — | — | 1 | 1 |
Show 18 more
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
No data
Target
No data
Variants
No data
Financial
No data
Trends
No data
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
37,969 adverse events reported
View more details
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use